Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1992
10/29/1992WO1992018465A1 Compounds for inhibition of protein methylation
10/29/1992WO1992018462A1 Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
10/29/1992WO1992018160A2 Method for inhibiting adhesion of white blood cells to endothelial cells
10/29/1992WO1992018142A1 Osteoinductive protein mixtures and purification processes
10/29/1992WO1992018124A1 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST
10/29/1992WO1992018110A1 Process for conditioning of water-soluble substances
10/29/1992WO1992018089A2 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells
10/29/1992WO1992016623A3 Receptors for bombesin-like peptides
10/29/1992WO1992008985A3 Ligand-mediated immunofunctional hormone binding protein assay method
10/29/1992DE4213005A1 Antikonzeption bei weiblichen primaten ohne beeinflussung des menstruellen zyklus Contraception in female primates without influencing the menstrual cycle
10/29/1992DE4200954A1 New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc.
10/29/1992CA2585487A1 Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons
10/29/1992CA2108566A1 Method for inhibiting adhesion of white blood cells to endothelial cells
10/29/1992CA2107790A1 Compounds for inhibition of protein methylation
10/28/1992EP0511188A2 Novel binding peptides
10/28/1992EP0511181A1 Saliva substitute
10/28/1992EP0511073A1 Antiserotonines, their preparation and medicaments containing them
10/28/1992EP0511072A1 2-Aminopyrimidin-4-carboxamid derivatives, their preparation and their therapeutical use
10/28/1992EP0510913A2 Pharmaceutical compositions comprising calcitonin
10/28/1992EP0510837A2 Synergistic combinations in the treatment of anxiety
10/28/1992EP0510813A1 Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
10/28/1992EP0510719A1 Benzimidazole derivatives substituted with a radical group and their use for inhibiting gastric acid secretion
10/28/1992EP0510662A1 bFGF mutein and its production
10/28/1992EP0510356A1 Polyethylene glycol protein conjugates
10/28/1992EP0510318A1 Compositions for the topical treatment of burns
10/28/1992EP0510186A1 Therapeutic uses of melanin
10/28/1992EP0510068A1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS
10/28/1992EP0510066A1 1-azetidyl and 1-hexamethylenimine alkyl or aryl bisphosphonic acids and their use as pharmacological agents
10/28/1992EP0509984A1 Method of preparing lysozyme dimers
10/28/1992EP0235205B1 Peptide analogues of mammalian insulin-like growth factor-1
10/28/1992CN1018827B Calcium independent camp phosphodiesterase inhibitor antidepressant
10/28/1992CA2067039A1 Neurotrophic peptide derivatives
10/27/1992WO1992019624A1 Antiserotonines, prepartion thereof and medicaments containing them
10/27/1992US5159097 Alkenoic acid derivatives
10/27/1992US5158981 Skin disorders, deodorants
10/27/1992US5158975 Use of stearidonic acid
10/27/1992US5158971 Pharmaceutical compounds
10/27/1992US5158967 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
10/27/1992US5158957 2-substituted ergolines
10/27/1992US5158947 Condensed heterocyclic compounds and psychopharmaceutical composition containing same
10/27/1992CA2108014A1 4-aryl-3-(heteroarylureido)quinoline derivatives
10/27/1992CA2103562A1 Antiserotonins, preparation thereof and medicaments containing them
10/27/1992CA2066931A1 Bfgf mutein and its production
10/27/1992CA2066834A1 Use of glycine/nmda receptor ligands for the treatment of drug dependence and withdrawal
10/27/1992CA1309557C Leukotriene antagonists
10/25/1992WO1992019254A1 α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
10/25/1992CA2106764A1 Ó-substituted polypeptides having therapeutic activity
10/25/1992CA2066960A1 2-aminopyrimidine-4-carboxamide derivatives, their preparation and their application in therapy
10/23/1992WO1992018163A1 Medicine for intraocular operation
10/23/1992CA2085732A1 Pharmaceutical composition for use in intraocular surgery
10/21/1992EP0509845A1 (+) and (-) enantiomers of 5-aliphatic-6-(benzoxazinyl- or benzothiazinyl)-2,3,4,5-tetrahydropyridazin-3-ones
10/21/1992EP0509769A2 Heterocyclic amides having HLE inhibiting activity
10/21/1992EP0509752A2 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
10/21/1992EP0509421A1 Hyperpigmentation of skin
10/21/1992EP0509317A2 Use of droloxifene in the treatment of bone diseases
10/21/1992EP0509088A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
10/21/1992EP0509080A1 Inhibitors and substrates of thrombin
10/21/1992EP0509027A1 A process to correct and optimize the composition of a feed.
10/21/1992EP0509009A1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent.
10/21/1992EP0481000A4 Receptors for fibroblast growth factors
10/21/1992EP0457856A4 Isolation growth and differentiation of human muscle cells
10/21/1992CN1065465A Polyethylene protein conjugates
10/21/1992CN1065460A Nonsaditive antihistaminics derived from benzimidazoles
10/21/1992CN1065458A Polytehoxylated vitamin e and a method for preparation thereof
10/20/1992WO1992018154A1 Human bone derived insulin like growth factor binding protein
10/20/1992US5157140 Esters of myo-inositol phosphate
10/20/1992US5157044 Analogs of carbonic anhydrase inhibitors and their use as topical IOP inhibitors
10/20/1992US5157041 Viricides
10/20/1992US5157040 Substituted quinolines as angiotensin ii antagonists
10/20/1992US5157039 2-quinolinyl methoxy compounds, medical uses and intermediates therefor
10/20/1992US5157038 Antidepressants; tranquilizers; treatment of schizophrenia and epilepsy; antilepmic agents
10/20/1992US5157020 Two covalently bonded peptides
10/20/1992CA2107475A1 Human bone derived insulin like growth factor binding protein
10/20/1992CA1309095C Aminoimidazoquinoline derivatives
10/20/1992CA1309087C Cyclodextrin clathrates of carbacyclin derivatives and their use as medicinal agents
10/20/1992CA1309046C Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
10/19/1992WO1992018003A1 Inhibitors of kynureninase
10/19/1992CA2108670A1 Inhibitors of kynureninase
10/19/1992CA2066311A1 (+) and (-) enantiomers of 5-aliphatic-6-(benzoxazinyl- or benzothiazinyl)-2,3,4,5-tetrahydropyridazin-3-ones
10/19/1992CA2065794A1 Heterocyclic amides
10/18/1992WO1992018546A1 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
10/18/1992WO1992018498A1 Pyrimidine derivatives for enhancing antitumor activity
10/18/1992CA2108569A1 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
10/18/1992CA2108561A1 Pyrimidine derivatives for enhancing antitumor activity
10/17/1992WO1992018481A1 Styryl-substituted heteroaryl compounds which inhibit egf receptor tyrosine kinase
10/17/1992CA2108367A1 Styryl-substituted heteroaryl compounds which inhibit egf receptor tyrosine kinase
10/16/1992WO1992018148A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/16/1992CA2108467A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/16/1992CA2065804A1 Hyperpigmentation of skin
10/15/1992WO1992017475A1 Heterocyclic-cyclic amine derivatives
10/15/1992WO1992017206A1 Wound healing
10/15/1992WO1992017178A1 Remedy for thrombosis and phosphodiesterase inhibitor
10/15/1992WO1992017172A1 Disubstituted naphthalenes
10/14/1992EP0508969A1 Process for conditioning of water-soluble substances
10/14/1992EP0508799A1 Cholecystokinin antagonists
10/14/1992EP0508797A1 Cholecystokinin antagonists
10/14/1992EP0508723A1 Angiotensin II antagonists incorporating an indole or dihydroindole
10/14/1992EP0508690A1 Tetronic and thiotetronic acid derivatives
10/14/1992EP0508672A2 Fish prolactin
10/14/1992EP0508425A1 Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
1 ... 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 ... 1564